DEXCOM INC R&D Expense 2009-2026 | DXCM
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is DEXCOM INC's current r&d expense?
DEXCOM INC (DXCM) annual r&d expense for 2025 was $599.1M, a 8.45% increase from 2024. DEXCOM INC r&d expense for the quarter ending March 31, 2026 was $145.3M.
What was DEXCOM INC's r&d expense in 2024?
DEXCOM INC annual r&d expense for 2024 was $552.4M, a 9.21% increase from 2023.
What was DEXCOM INC's r&d expense in 2023?
DEXCOM INC annual r&d expense for 2023 was $505.8M, a 4.46% increase from 2022.
What is DEXCOM INC's 5-year r&d expense CAGR?
DEXCOM INC r&d expense grew at a compound annual growth rate (CAGR) of 10.73% from FY2020 to FY2025, going from $359.9M to $599.1M over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+10.7%
FY2020
$359.9M
→
FY2025
$599.1M
0910111213141516171819202122232425
5 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $599.1M | +8.5% | 10-K |
| FY2024 | $552.4M | +9.2% | 10-K |
| FY2023 | $505.8M | +4.5% | 10-K |
| FY2022 | $484.2M | -6.4% | 10-K |
| FY2021 | $517.1M | +43.7% | 10-K |
| FY2020 | $359.9M | +31.6% | 10-K |
| FY2019 | $273.5M | +37.0% | 10-K |
| FY2018 | $199.7M | +7.7% | 10-K |
| FY2017 | $185.4M | +18.8% | 10-K |
| FY2016 | $156.1M | +13.5% | 10-K |
| FY2015 | $137.5M | +98.1% | 10-K |
| FY2014 | $69.4M | +54.9% | 10-K |
| FY2013 | $44.8M | +17.0% | 10-K |
| FY2012 | $38.3M | +29.4% | 10-K |
| FY2011 | $29.6M | +27.6% | 10-K |
| FY2010 | $23.2M | +62.3% | 10-K |
| FY2009 | $14.3M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →